[Still questions around the slimming agent rimobant. Not approved in USA because of the risk of mental adverse effects]

Lakartidningen. 2007 Dec 19;104(51-52):3879-81.
[Article in Swedish]
No abstract available

MeSH terms

  • Anti-Obesity Agents / adverse effects*
  • Cannabinoid Receptor Antagonists*
  • Depression / chemically induced*
  • Drug Approval
  • Humans
  • Obesity / drug therapy
  • Piperidines / adverse effects*
  • Pyrazoles / adverse effects*
  • Rimonabant
  • Risk Factors
  • Weight Loss / drug effects

Substances

  • Anti-Obesity Agents
  • Cannabinoid Receptor Antagonists
  • Piperidines
  • Pyrazoles
  • Rimonabant